Cochrane Abstracts
Postoperative tamoxifen for ductal carcinoma in situ
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Postoperative Tamoxifen for Ductal Carcinoma in Situ." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431689/all/Postoperative_tamoxifen_for_ductal_carcinoma_in_situ.
Postoperative tamoxifen for ductal carcinoma in situ. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431689/all/Postoperative_tamoxifen_for_ductal_carcinoma_in_situ. Accessed November 15, 2024.
Postoperative tamoxifen for ductal carcinoma in situ. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431689/all/Postoperative_tamoxifen_for_ductal_carcinoma_in_situ
Postoperative Tamoxifen for Ductal Carcinoma in Situ [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431689/all/Postoperative_tamoxifen_for_ductal_carcinoma_in_situ.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Postoperative tamoxifen for ductal carcinoma in situ
ID - 431689
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431689/all/Postoperative_tamoxifen_for_ductal_carcinoma_in_situ
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
